- Home
- IDYA vs SM Comparison
IDYA vs SM Comparison
Compare IDYA & SM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- SM
- Stock Information
- Founded
- IDYA 2015
- SM 1908
- Country
- IDYA United States
- SM United States
- Employees
- IDYA N/A
- SM N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- SM Oil & Gas Production
- Sector
- IDYA Health Care
- SM Energy
- Exchange
- IDYA Nasdaq
- SM Nasdaq
- Market Cap
- IDYA 2.9B
- SM 2.4B
- IPO Year
- IDYA 2019
- SM 1992
- Fundamental
- Price
- IDYA $34.21
- SM $18.26
- Analyst Decision
- IDYA Buy
- SM Hold
- Analyst Count
- IDYA 14
- SM 10
- Target Price
- IDYA $49.58
- SM $37.25
- AVG Volume (30 Days)
- IDYA 992.0K
- SM 3.5M
- Earning Date
- IDYA 11-04-2025
- SM 11-03-2025
- Dividend Yield
- IDYA N/A
- SM 4.37%
- EPS Growth
- IDYA N/A
- SM N/A
- EPS
- IDYA N/A
- SM 6.33
- Revenue
- IDYA $214,834,000.00
- SM $3,166,673,000.00
- Revenue This Year
- IDYA $90.17
- SM $33.20
- Revenue Next Year
- IDYA $217.29
- SM N/A
- P/E Ratio
- IDYA N/A
- SM $2.89
- Revenue Growth
- IDYA 5377.66
- SM 35.48
- 52 Week Low
- IDYA $13.45
- SM $17.58
- 52 Week High
- IDYA $34.66
- SM $46.42
- Technical
- Relative Strength Index (RSI)
- IDYA 68.23
- SM 36.21
- Support Level
- IDYA $31.15
- SM $18.00
- Resistance Level
- IDYA $34.66
- SM $19.72
- Average True Range (ATR)
- IDYA 1.58
- SM 0.95
- MACD
- IDYA 0.11
- SM 0.18
- Stochastic Oscillator
- IDYA 89.86
- SM 28.74
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About SM SM Energy Company
SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and NGLs in Texas and Utah. Its portfolio is comprised of assets in the Midland Basin of West Texas, the Maverick Basin of South Texas, and the Uinta Basin of northeastern Utah.